Analysis of clinical characteristics and impact on the expression of molecules related to JAK/STAT signaling pathway in the treatment of systemic lupus erythematosus in children with belimumab

LI Feng; CHEN Hui-shan; TANG Ying; ZENG Ping; ZENG Hua-song

doi:10.19538/j.ek2023120611

Home>Articles>Analysis of clinical characteristics and impact on the expression of molecules related to JAK/STAT signaling pathway in the treatment of systemic lupus erythematosus in children with belimumab

DOI: 10.19538/j.ek2023120611

Analysis of clinical characteristics and impact on the expression of molecules related to JAK/STAT signaling pathway in the treatment of systemic lupus erythematosus in children with belimumab

LI Feng

CHEN Hui-shan

TANG Ying

ZENG Ping

ZENG Hua-song

Keywords：systemic lupus erythematosusbelizumabJAK/STAT signaling pathwayinflammatory factors

Publication Date：2023-12-06

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：8( 924-931 )

Chinese Journal of Practical Pediatrics

ISTICPKUCSCD

ISSN：1005-2224

Year, Vol.(Issue)：2023,38(12)